Document Detail


Organizational effects of testosterone via aromatization on feminine reproductive behavior and neural progestin receptors in rat brain.
MedLine Citation:
PMID:  6479096     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present studies were undertaken to determine whether estrogenic actions of testosterone during development govern the apparently irreversible suppression of feminine reproductive behavior in the male and lead to a suppression of the capacity of the ventromedial nucleus (VMN) of the hypothalamus to produce cytosol progestin receptors (CPRs) in response to estrogen priming. Timed-pregnant female rats received daily injections of the aromatase inhibitor 1,4,6-androstatriene-3,17-dione (ATD; 5 mg/0.2 ml) from the 14th day of pregnancy until parturition. Males exposed to ATD in utero received Silastic capsules containing ATD for the first 10 days of life. Some females from litters not exposed to ATD received injections of estradiol benzoate (EB; 10 micrograms) 6-12 h and 3 days after birth. The remaining pups not exposed to ATD served as controls. Pups were gonadectomized on days 60-70 and were tested for feminine reproductive behavior or killed for CPR measurements on days 85-90. To elicit behavior, animals received daily injections of EB (15 micrograms for 3 days) and one injection of progesterone (500 micrograms) 4 h before testing. To induce CPRs, animals received EB but not progesterone. Significantly less receptive and proceptive behavior was observed in males and females given perinatal EB than in normal females and males given perinatal ATD. The CPR content of the VMN in males was similar to that in females given perinatal EB and significantly less than that in normal females and males given perinatal ATD. Neonatal hormonal manipulation did not alter the CPR content of other hypothalamic or preoptic nuclei. These findings are consistent with the hypothesis that one event mediated by estradiol which underlies activation of feminine reproductive behavior is the induction of CPRs in the VMN. This capacity is apparently restricted by estrogen-mediated events in males during the perinatal period.
Authors:
B Parsons; T C Rainbow; B S McEwen
Related Documents :
8037886 - Testosterone has rewarding affective properties in male rats: implications for the biol...
7413786 - Sexual receptivity in female rats after lesion or stimulation in different amygdaloid n...
1523256 - Effects of thymectomy on reproductive function and behavior.
1508396 - Concurrent wet dog shaking and inhibition of male rat copulation after ventromedial bra...
503266 - Body fluid changes in hypertensive rats. their modifications by saline load.
22665676 - Milk production in sows from a teat in second parity is influenced by whether it was su...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Endocrinology     Volume:  115     ISSN:  0013-7227     ISO Abbreviation:  Endocrinology     Publication Date:  1984 Oct 
Date Detail:
Created Date:  1984-11-01     Completed Date:  1984-11-01     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0375040     Medline TA:  Endocrinology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1412-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Androstatrienes / pharmacology
Animals
Aromatase / metabolism*
Cytosol / metabolism
Estradiol / pharmacology
Female
Neurons / metabolism
Oxidoreductases / metabolism*
Pregnancy
Prenatal Exposure Delayed Effects
Rats
Rats, Inbred Strains
Receptors, Progesterone / metabolism*
Reproduction
Sexual Behavior, Animal*
Testosterone / physiology*
Ventromedial Hypothalamic Nucleus / physiology*
Grant Support
ID/Acronym/Agency:
NS-07080/NS/NINDS NIH HHS; NS-20006/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Androstatrienes; 0/Receptors, Progesterone; 50-28-2/Estradiol; 58-22-0/Testosterone; 633-35-2/androsta-1,4,6-triene-3,17-dione; EC 1.-/Oxidoreductases; EC 1.14.14.1/Aromatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of two forms of molybdate-stabilized estrogen receptor.
Next Document:  Pregnancy in young and aged rats. I. Ovarian progesterone and 20 alpha-hydroxypregn-4-en-3-one forma...